Booster vaccines found to augment T-cell responses to SARS-CoV-2 Omicron
![](./upload/news/image_1644223276_41895421.jpg)
In a recent study published in the latest issue of the journal Cell, a team of researchers evaluated T-cell reactivity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant's spike (S) and non-spike proteins.